We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 21-40 of 2,117 results
  1. Strategic CMC-Focused Interactions with Regulatory Authorities

    The development, design and control of a biopharmaceutical manufacturing process to obtain product of required quality, safety and efficacy, has...
    Chapter 2023
  2. Seemingly Endless Biomolecular Structural Variants

    Compared to chemical drugs, biopharmaceuticals have a highly complex, seemingly endless, biomolecular structural variant profile, especially due to...
    Chapter 2023
  3. Modification and preparation of four natural hydrogels and their application in biopharmaceutical delivery

    Hydrogels possess a unique three-dimensional structure into which many drugs can be incorporated. The hydrogels slow down the release rate of drugs,...

    He Mengyuan, Wang Changlin, ... Cong Zhufeng in Polymer Bulletin
    Article 11 August 2022
  4. Risk Management of the Minimum CMC Regulatory Compliance Continuum

    The challenge of control of the biopharmaceutical manufacturing process coupled with the complexity of the resulting biopharmaceutical products...
    Chapter 2023
  5. Indispensable Potency (Biological Activity)

    The measurement of potency (strength) is a regulatory requirement for all pharmaceuticals. For chemical drugs, the potency is determined by measuring...
    Chapter 2023
  6. A critical review of recent trends, and a future perspective of optical spectroscopy as PAT in biopharmaceutical downstream processing

    As competition in the biopharmaceutical market gets keener due to the market entry of biosimilars, process analytical technologies (PATs) play an...

    Laura Rolinger, Matthias RĆ¼dt, JĆ¼rgen Hubbuch in Analytical and Bioanalytical Chemistry
    Article Open access 07 March 2020
  7. Complex Process-Related Impurity Profiles

    Every manufactured human medicine contains residual impurities associated with its manufacturing process. Patient safety risk associated with the...
    Chapter 2023
  8. FT-IR versus EC-QCL spectroscopy for biopharmaceutical quality assessment with focus on insulinā€”total protein assay and secondary structure analysis using attenuated total reflection

    For the quality control of biopharmaceutical products, which contain proteins as the most important active ingredients, shelf life may be limited due...

    Sven Delbeck, H. Michael Heise in Analytical and Bioanalytical Chemistry
    Article Open access 01 June 2020
  9. Solubility of lamotrigine in age-specific biorelevant media that simulated the fasted- and fed-conditions of the gastric and intestinal environments in pediatrics and adults: implications for traditional, re-formulated, modified, and new oral formulations

    Background

    Lamotrigine is an effective antiseizure medication that can be used in the management of focal and generalized epilepsies in pediatric...

    Ramzi Shawahna, Hala Sabaā€™aneh, ... Xavier DeclĆØves in BMC Biotechnology
    Article Open access 08 September 2023
  10. Inclusion Bodies: Status Quo and Perspectives

    Multiple E. coli cultivations, producing recombinant proteins, lead to the formation of inclusion bodies (IBs). IBs historically were considered as...
    Julian Kopp, Oliver Spadiut in Inclusion Bodies
    Protocol 2023
  11. Differences in CMC Regulatory Compliance: Biopharmaceuticals Versus Chemical Drugs

    Regulatory compliance is essential for patient protection, and it applies both to Clinical as well as to Chemistry, Manufacturing & Controls (CMC)....
    Chapter 2023
  12. Chinese Hamster Ovary Cell Line Instability: Causes, Mitigation, and Prediction

    Cell line instability is a common problem in biopharmaceutical manufacturing using Chinese hamster ovary (CHO) cells. Cell line instability, which...

    Yun Joo, Hagyeong Kim, Jong Youn Baik in Biotechnology and Bioprocess Engineering
    Article 01 October 2023
  13. Metaheuristic approaches in biopharmaceutical process development data analysis

    There is a growing interest in mining and handling of big data, which has been rapidly accumulating in the repositories of bioprocess industries....

    Nishanthi Gangadharan, Richard Turner, ... Duygu Dikicioglu in Bioprocess and Biosystems Engineering
    Article Open access 22 May 2019
  14. Regulatory Pathways Impacting Biopharmaceuticals

    To obtain market approval from a regulatory authority for a new medicine, manufacturers must first initiate and then complete human clinical trials....
    Chapter 2023
  15. Mixed-Mode Chromatography and Its Role in Monoclonal Antibody Purification

    As the biopharmaceutical industry matures and embraces process intensification methodologies allied to the emergence of newer personalized medicines,...
    John Joseph Milne in Protein Chromatography
    Protocol 2023
  16. Development and evaluation of orbital rocking motion-based single-use cell culture system, the CELBICĀ® system

    The importance of a single-use bioreactor (SUB) is continuously increasing in research and industrial fields for biopharmaceutical production. In...

    Hyunwoo Kim, Seohyun Park, ... Duk Jae Oh in Biotechnology and Bioprocess Engineering
    Article 16 March 2024
  17. Nano-delivery Systems and Therapeutic Applications of Phytodrug Mangiferin

    In order to cure a range of ailments, scientists have investigated a number of bioactive antioxidant compounds produced from natural sources....

    Madhuri Baghel, Ishita Baghel, ... Hemant Badwaik in Applied Biochemistry and Biotechnology
    Article 25 March 2024
  18. Scale-Up of Protein Purification: Downstream Processing Issues

    Large-scale chromatography operations continue to occupy the central position in the overall strategy for downstream processing and purification of...
    John Joseph Milne in Protein Chromatography
    Protocol 2023
  19. Cell Culture Models and Nanobiotechnology for Advanced Drug Delivery Research

    Cell culture is a term that describes research methods which enable both cells prokaryotic or eukaryotic to grow in physiological environments. In...
    Ramsha Khalid, Syed Mahmood, ... Nasrin Khodapanah in Recent Progress in Nanobiotechnology
    Chapter 2024
  20. Bioprocess Challenges in Purification of Therapeutic Protein Charge Variants

    Biopharmaceuticals are complex therapeutic protein molecules produced in living cells and have been a major driving force for drug development in the...

    Tarun Gupta, Anuj Kumar, Sriram Seshadri in Biotechnology and Bioprocess Engineering
    Article 29 May 2023
Did you find what you were looking for? Share feedback.